The present study further shows that iRGD induces a tumour-blood transport of the important clinical tumour marker PSA in mice with prostate cancer, and of autotaxin, which has no tumour marker properties without iRGD, in HCC mice. Here, KLK3 is linked to prostate carcinoma.